# Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma

> **NCT04203472** · NA · COMPLETED · sponsor: **Medical University of Warsaw** · enrollment: 22 (actual)

## Conditions studied

- Asthma
- Cough Variant Asthma

## Interventions

- **DEVICE:** Budesonid or budesonide/fomoterol administered by DPI
- **DEVICE:** Budesonid or budesonide/fomoterol administered by MDI

## Key facts

- **NCT ID:** NCT04203472
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-20
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-03-30
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04203472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04203472, "Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04203472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*